RECRUITING

Understanding Ketamine's Dissociative Effects (KD Study)

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Official Title

Understanding Ketamine's Dissociative Effects in Epilepsy (KD Study)

Quick Facts

Study Start:2021-07-26
Study Completion:2028-08-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04861051

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient in Stanford Epilepsy Monitoring Unit
  2. * Age \>18 years old.
  1. * Lifetime psychotic or bipolar disorder
  2. * Inability to speak, read or understand English
  3. * Pregnant or nursing females
  4. * Prior adverse ketamine response

Contacts and Locations

Study Contact

Arjay Cordero
CONTACT
650-580-9000
arjayc@stanford.edu

Principal Investigator

Karl Deisseroth, MD, PhD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford University School of Medicine
Palo Alto, California, 94305
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Karl Deisseroth, MD, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-26
Study Completion Date2028-08-01

Study Record Updates

Study Start Date2021-07-26
Study Completion Date2028-08-01

Terms related to this study

Additional Relevant MeSH Terms

  • Epilepsy